Successful biotechnology companies know that when it comes to selecting a location for their business, two factors top the list: a strong research capacity and an economic environment that can transform research into successful commercial activity. Across the nation, 9 regions have proven to be leaders in these areas and account for 75% of the country's biotech firms, as well as 75% of the biotech companies born within the last 10 years. 4 of these metropolitan areas are concentrated within the Mid-Atlantic region.
One area, located strategically within the heart of this corridor, is poised to become the next biotechnology hot spot: Lehigh Valley, PA.
Located on the New Jersey-Pennsylvania border, the Lehigh Valley is rapidly gaining recognition within the biotechnology and pharmaceutical industries for its ability to meet the diverse needs of both evolving and established businesses in these sectors. In April 2006, LVEDC, the Southside Bethlehem Keystone Innovation Zone (KIZ), which is administered by LVEDC, and KLIOS, Inc. completed a Life Sciences Study to investigate and assess the possible growth of the life sciences industry in the Lehigh Valley, and to define a series of recommendations for strategies and actions to support that growth.
Olympus, a precision technology leader that is designing and delivering innovative solutions in healthcare and consumer electronics worldwide, recently announced their plans to relocate its North American headquarters from Long Island, New York to Lehigh Valley, Pennsylvania.To find out more about the BioPharm industry in Pennsylvania, please visit the following sites: